Question 1

Am I eligible for this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence clinical trial (NCT06430541). Contact the study team or your healthcare provider for specific answers.

Question 2

How does psilocybin-assisted therapy compare to other treatments for fear of recurrence?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence clinical trial (NCT06430541). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of psilocybin, and how will they be monitored?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence clinical trial (NCT06430541). Contact the study team or your healthcare provider for specific answers.

Question 4

What does the treatment schedule look like, and how often will I need to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence clinical trial (NCT06430541). Contact the study team or your healthcare provider for specific answers.

Question 5

What kind of support will I receive during and after the psilocybin treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence clinical trial (NCT06430541). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my progress be measured throughout the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence clinical trial (NCT06430541). Contact the study team or your healthcare provider for specific answers.

What this study is about